Connection

Jacques Izopet to France

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about France.
Jacques Izopet
Connection Strength
0.742
France
  1. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 06 15; 11(1):12597.
    View in: PubMed
    Score: 0.070
  2. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.069
  3. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8.
    View in: PubMed
    Score: 0.069
  4. Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France. J Infect. 2021 May; 82(5):186-230.
    View in: PubMed
    Score: 0.068
  5. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2021 03; 82(3):414-451.
    View in: PubMed
    Score: 0.067
  6. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32.
    View in: PubMed
    Score: 0.066
  7. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect. 2020 Aug; 81(2):318-356.
    View in: PubMed
    Score: 0.065
  8. Diversity of hepatitis E virus genotype 3. Rev Med Virol. 2018 09; 28(5):e1987.
    View in: PubMed
    Score: 0.057
  9. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017 07; 23(7):1191-1193.
    View in: PubMed
    Score: 0.053
  10. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg Infect Dis. 2017 02; 23(2):353-356.
    View in: PubMed
    Score: 0.052
  11. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfus Med Rev. 2019 07; 33(3):146-153.
    View in: PubMed
    Score: 0.015
  12. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother. 2019 05 01; 74(5):1417-1424.
    View in: PubMed
    Score: 0.015
  13. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.014
  14. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.014
  15. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: a one-year experiment in central France, 2014 to 2015. Euro Surveill. 2018 02; 23(7).
    View in: PubMed
    Score: 0.014
  16. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017 11; 67(5):925-932.
    View in: PubMed
    Score: 0.013
  17. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. J Antimicrob Chemother. 2017 06 01; 72(6):1769-1773.
    View in: PubMed
    Score: 0.013
  18. Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection. J Clin Microbiol. 2010 Oct; 48(10):3487-91.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.